Page last updated: 2024-11-04

terbutaline and Cardiomyopathy, Hypertrophic

terbutaline has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Walker, AL1
Ueda, Y1
Crofton, AE1
Harris, SP1
Stern, JA1

Other Studies

1 other study available for terbutaline and Cardiomyopathy, Hypertrophic

ArticleYear
Ambulatory electrocardiography, heart rate variability, and pharmacologic stress testing in cats with subclinical hypertrophic cardiomyopathy.
    Scientific reports, 2022, 02-04, Volume: 12, Issue:1

    Topics: Administration, Oral; Adrenergic beta-2 Receptor Agonists; Animals; Arrhythmias, Cardiac; Asymptomat

2022